Efficacy and toxicity of surufatinib in neuroendocrine tumors: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Efficacy and toxicity of surufatinib in neuroendocrine tumors: A systematic review and meta‐analysis

Published:2022-06-04 Issue:7 Volume:34 Page:
ISSN:0953-8194
Container-title:Journal of Neuroendocrinology
language:en
Short-container-title:J Neuroendocrinology

Author:

Ali Muhammad Ashar¹^ORCID,Shah Syed S.²,Tahir Nayha³,Rehman Sana⁴,Saeed Memoona⁵,Bajwa Shammas Farooq⁶,Ali Rimsha⁷,Aiman Wajeeha¹,Anwar Muhammad Yasir⁸

Affiliation:

1. Beth Israel Deconess Medical Center Harvard Medical School Boston Massachusetts USA

2. University of Kentucky Lexington Kentucky USA

3. Rosalind Franklin University of Medical Sciences/Chicago Medical School North Chicago Illinois USA

4. Shaikh Khalifa Bin Zayed Al Nahyan Medical and Dental College Lahore Pakistan

5. King Edward Medical University Lahore Pakistan

6. AdvantHealth Orlando Orlando Florida USA

7. Rawalpindi Medical College Rawalpindi Pakistan

8. BronxCare Hospital Center Bronx New York USA

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jne.13149

Reference39 articles.

1. Neuroendocrine Neoplasms: Dichotomy, Origin and Classifications

2. Prognosis of patients with neuroendocrine tumor: a SEER database analysis

3. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

4. Bone metastases and skeletal-related events from neuroendocrine tumors

5. Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecule protein kinase inhibitors approved by regulatory agencies outside of the United States;Pharmacological Research;2023-08